Clinical Trial Hits Of 2025

perspectives 2026
Arrows hitting targets
FDA's Office of Generic Drugs understands the importance of hitting the mark on user fee goal dates. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Scrip Perspectives

More from Anticancer